# iVEAcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iveacare

- Industry: Medical Devices & Equipment
- Headquarters: Minneapolis, US
- Website: www.iveacare.com/
- Total disclosed funding: $16M
- Latest round: Series A (Apr 12, 2024)
- Investors on record: 3

## About

Based in Minnesota, US, and founded in 2023 by President and Chief Executive Officer Todd Kerkow, co-founders Mudit K. Jain and Lynn Elliott, iVEAcare operates as a manufacturing company providing neuromodulation therapies for clinical needs in patients suffering from chronic diseases. In April 2024, iVEAcare raised USD 27.5 million in Series A funding led by Vensana Capital with participation from Treo Ventures and Hatteras Venture Partners.

iVEAcare developed and commercialized neuromodulation technology platforms to treat chronic diseases. The company creates hardware and software that allows doctors to target specific areas of the brain or spinal cord with electrical stimulation and this allows healthcare professionals to improve therapies that can be provided to a larger patient base.

## Funding rounds

- Series A, Apr 12, 2024, $16M — Hatteras Venture Partners, Treo Ventures, Vensana Capital

## Investors

- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A
- Treo Ventures (https://capitalatlas.ai/funds/treo-ventures) — Series A
- Vensana Capital (https://capitalatlas.ai/funds/vensana-capital) — Series A